March 14, 2011 – A software system that manages patient itineraries has expanded into the cardiology and transport departments. Allocade’s On-Cue Expert Software System and enhancements for the On-Cue Dynamic Patient Itinerary information were demonstrated at the Healthcare Information and Management Systems Society (HIMSS) 2011 conference.

March 14, 2011 – A vascular graft for hemodialysis access has received the CE mark. The Gore Propaten vascular graft, from W.L. Gore and Associates, utilizes a covalent bonding technology to adhere heparin to the graft surface.


Medical device companies spend around $1 million at the front end of every device development project to get to a product concept that they want to take to market. Some vendors spend it better than others, according to Sagentia, a company that works with device vendors to develop new technologies, products and services.

March 11, 2011 – DR Systems will exhibit its Unity Cardiovascular Information System (CVIS) at next month’s American College of Cardiology (ACC) meeting.

The system provides a cost effective, comprehensive cardiology solution for institutions that need a new cardiology system whether replacing aging, limited systems or moving from tape to a digital solution.

March 11, 2011 – U.S. Food and Drug Administration (FDA) and Lantheus Medical Imaging Inc. today reached agreement on a phase 3 clinical trial design to assess myocardial perfusion using flurpiridaz F18 positron emission tomography (PET) imaging in patients with suspected or known coronary artery disease (CAD).

March 11, 2011 – Sildenafil, a drug used to treat erectile dysfunction and pulmonary hypertension, has another possible use – helping children and young adults with congenital heart disease to better tolerate exercise.

March 11, 2011 – Texas Children's has become the world's first pediatric hospital to complete the first phase of certification to implant the SynCardia temporary Total Artificial Heart. The hospital intends to use the device as a bridge to transplant for their patients who received a heart transplant as children and now require mechanical support as a bridge to their second transplant.

March 11, 2011 – The U.S. Food and Drug Administration (FDA) has approved a surgical kit that allows neurosurgeons to reroute blood flow around an aneurysm or a tumor in the brain. This should help patients at greater risk of stroke during standard bypass surgery.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now